Header Logo

Connection

Karen Wernli to Early Detection of Cancer

Back to Details
This is a "connection" page, showing publications Karen Wernli has written about Early Detection of Cancer.
Karen Wernli
Connection Strength
4.277
Early Detection of Cancer
  1. Understanding Patient and Clinical Stakeholder Perspectives to Improve Adherence to Lung Cancer Screening. Perm J. 2021 Jun 02; 25.
    View in: PubMed
    Score: 0.523
  2. Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016. Cancer. 2020 12 15; 126(24):5293-5302.
    View in: PubMed
    Score: 0.500
  3. Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis. Breast Cancer Res Treat. 2020 Jun; 181(2):255-268.
    View in: PubMed
    Score: 0.484
  4. A qualitative study exploring patient motivations for screening for lung cancer. PLoS One. 2018; 13(7):e0196758.
    View in: PubMed
    Score: 0.428
  5. Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline. J Womens Health (Larchmt). 2017 08; 26(8):820-827.
    View in: PubMed
    Score: 0.388
  6. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016 Jul 26; 316(4):436-47.
    View in: PubMed
    Score: 0.374
  7. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1230-7.
    View in: PubMed
    Score: 0.320
  8. Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med. 2014 Jan; 174(1):125-32.
    View in: PubMed
    Score: 0.313
  9. Knowledge and Perception of Breast Density, Screening Mammography, and Supplemental Screening: in Search of "Informed". J Gen Intern Med. 2020 06; 35(6):1654-1660.
    View in: PubMed
    Score: 0.118
  10. Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk. J Womens Health (Larchmt). 2018 06; 27(6):748-754.
    View in: PubMed
    Score: 0.104
  11. Performance Benchmarks for Screening Breast MR Imaging in Community Practice. Radiology. 2017 10; 285(1):44-52.
    View in: PubMed
    Score: 0.099
  12. A qualitative study exploring why individuals opt out of lung cancer screening. Fam Pract. 2017 04 01; 34(2):239-244.
    View in: PubMed
    Score: 0.098
  13. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1147-58.
    View in: PubMed
    Score: 0.081
  14. Use of interactive voice response to improve colorectal cancer screening. Med Care. 2014 Jun; 52(6):496-9.
    View in: PubMed
    Score: 0.081
  15. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013 May 13; 173(9):807-16.
    View in: PubMed
    Score: 0.075
  16. Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer. J Clin Oncol. 2023 Feb 01; 41(4):859-870.
    View in: PubMed
    Score: 0.036
  17. Women's Breast Cancer Screening Confidence by Screening Modality and Breast Density: A Breast Cancer Surveillance Consortium Survey Study. J Womens Health (Larchmt). 2022 11; 31(11):1547-1556.
    View in: PubMed
    Score: 0.036
  18. Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study. Prev Med. 2021 10; 151:106542.
    View in: PubMed
    Score: 0.033
  19. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity. JAMA Netw Open. 2021 03 01; 4(3):e211974.
    View in: PubMed
    Score: 0.032
  20. Prior breast density awareness, knowledge, and communication in a health system-embedded behavioral intervention trial. Cancer. 2020 04 15; 126(8):1614-1621.
    View in: PubMed
    Score: 0.030
  21. A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system. Contemp Clin Trials. 2017 05; 56:25-33.
    View in: PubMed
    Score: 0.024
  22. Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med. 2016 08; 89:169-177.
    View in: PubMed
    Score: 0.023
  23. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. 2016 Feb 15; 122(4):611-7.
    View in: PubMed
    Score: 0.022
  24. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013 Nov 15; 119(22):3959-67.
    View in: PubMed
    Score: 0.019
  25. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013 Mar 06; 105(5):334-41.
    View in: PubMed
    Score: 0.018
  26. The impact of obesity on follow-up after an abnormal screening mammogram. Cancer Epidemiol Biomarkers Prev. 2012 Feb; 21(2):327-36.
    View in: PubMed
    Score: 0.017

© 2024 Kaiser Permanente